Geneva, March 23 -- International Clinical Trials Registry received information related to the study (KCT0011717) titled 'Phase 1 Study of MP101 in Adults With Acute Pseudomonas aeruginosa Pneumonia' on March 12.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Caregiver, Allocation : RCT
Primary Sponsor: MicrobiotiX
Condition:
Diseases of the respiratory system
Intervention:
Biological/Vaccine, Non-Stem Cell : This clinical trial is a Phase 1 study with a randomized, double-blind, placebo-controlled, single-dose, sequential dose-escalation design and consists of two dose cohorts. After the safety of the...